Lorazepam
- Product NDC
- 63304-772
- Requested package NDC
- 63304-772-90
- 11-digit product format
- 633040772
- Labeler code
- 63304
- Product ID
- 63304-772_b8fbb599-96d9-4866-908d-d8be424e5ee3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- SUN PHARMACEUTICAL INDUSTRIES INC
- Application
- ANDA076045
- Marketing category
- ANDA
- Marketing start
- 2023-06-25
- Substance
- LORAZEPAM
- Active strength
- .5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076045-001 | LORAZEPAM | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | |
| A076045-002 | LORAZEPAM | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | |
| A076045-003 | LORAZEPAM | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076045-001 | AB |
| A076045-002 | AB |
| A076045-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076045-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2001-08-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076045-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2001-08-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076045-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2001-08-29 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A076045-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076045-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A076045-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A076045-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076045-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A076045-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076045-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076045-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076045-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A076045-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076045-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A076045-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076045-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076045-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076045-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076045-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076045-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076045-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076045-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076045-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076045-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076045-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076045-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076045-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076045-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076045-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076045-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076045-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076045-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076045-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A076045-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A076045-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A076045-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076045-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076045-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076045-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076045-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076045-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076045-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076045-001 | AB | 1 | 1e350fbaab3a… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lorazepam
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LORAZEPAM | .5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| O26FZP769L | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0c1caa9c-9ef1-459c-86c3-adb939130a9f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a759f740-8682-4896-9194-8b6c103c9aee | Product name | 3 | 20250716 |
| b7badb1c-6d3f-4f95-a4ca-ce69992e58a1 | Product name | 1 | 20220308 |
| 5d98a0ba-a64b-d9b2-e6ec-87edbb57a285 | Product name | 2 | 20180320 |
| ac8efea8-f412-295f-00ce-b095e5cbc115 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 63304-772-01 | 2023-07-06 | Lorazepam Tablets, USP CIV |
| 63304-772-05 | 2023-07-06 | Lorazepam Tablets, USP CIV |
| 63304-772-10 | 2023-07-06 | Lorazepam Tablets, USP CIV |
| 63304-772-30 | 2023-07-06 | Lorazepam Tablets, USP CIV |
| 63304-772-90 | 2023-07-06 | Lorazepam Tablets, USP CIV |
| 63304-772-01 | 2020-01-31 | Lorazepam Tablets, USP CIV |
| 63304-772-05 | 2020-01-31 | Lorazepam Tablets, USP CIV |
| 63304-772-10 | 2020-01-31 | Lorazepam Tablets, USP CIV |
| 63304-772-30 | 2020-01-31 | Lorazepam Tablets, USP CIV |
| 63304-772-90 | 2020-01-31 | Lorazepam Tablets, USP CIV |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-772-01 | Lorazepam | 100 in 1 BOTTLE | TABLET | 100 | 4 | |
| 63304-772-05 | Lorazepam | 500 in 1 BOTTLE | TABLET | 500 | 4 | |
| 63304-772-10 | Lorazepam | 1000 in 1 BOTTLE | TABLET | 1000 | 4 | |
| 63304-772-90 | Lorazepam | 90 in 1 BOTTLE | TABLET | 90 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63304-772-01 | EA - Each | 63304-772 | 17f34372-fe50-43d2-8bf6-9ac82f69f753 | 1 | 2012-07-24 |
| 63304-772-05 | EA - Each | 63304-772 | 12a9e0b0-c415-4aec-88e8-83f5d133916b | 1 | 2012-07-24 |
| 63304-772-90 | EA - Each | 63304-772 | 8729030d-12a9-41cf-a41d-dce5221a07e3 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 86630bdd-13ad-4ab5-9e94-fcf2ea2113e1 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 17919c82-87f2-5030-e063-6294a90ac91a | 2025-04-21 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1791d5c9-9004-5c4b-e063-6294a90adf3d | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals, Inc. | 29f63525-2839-946c-e063-6294a90aebb1 | 2024-12-23 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | Asclemed USA, Inc. | ebdf72f7-7462-4b83-81b4-c7988860c728 | 2024-11-05 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1bcf608a-11c1-ec7d-e063-6394a90ab710 | 2024-06-26 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 82f79757-69f0-4a37-93a6-55b66ae86ad7 | 2024-02-06 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 0ce02d7d-d855-c73f-e063-6294a90abe93 | 2023-12-19 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 |
| Lorazepam | LORAZEPAM | SUN PHARMACEUTICAL INDUSTRIES INC | 0c1caa9c-9ef1-459c-86c3-adb939130a9f | 2023-06-30 | Boxed warning, Warnings, Adverse reactions | 076045 ANDA076045 63304-772-90 63304-772 63304077290 |
DailyMed RxNorm Mappings#
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63304-772-90 | 63304077290 | 90 TABLET in 1 BOTTLE (63304-772-90) | 90 tablet | 2023-06-25 | No | No | Current |